
New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Read more
We are thrilled to announce that our T-Control® urinary catheter has officially received the CE Mark, certifying its compliance with European safety and performance standards.
This milestone is the result of years of dedication, research, and a shared mission: to improve patient quality of life, support healthcare professionals, and reduce environmental impact in hospital settings.
Designed with real clinical practice in mind, T-Control® provides a unique solution to address key challenges associated with one of the most widely used medical devices: the urinary catheter.
A heartfelt thank you to our team, partners, and collaborators who made this achievement possible — we’re just getting started!

Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Read more
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Read more
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.
Read more